Breast Neoplasms: all 12,828 studies
Page 63 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Cilostazol in Prevention of Peripheral NeuropathyCompletedNCT05298696Phase 1/2
- Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer PatientsStatus unknownNCT05298072
- Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant TreatmentCompletedNCT05297773Not applicable
- Effects of Extracorporeal Shock Wave Therapy Added To Complex DecongestiveTherapy In Patıent With LymphedemeStatus unknownNCT05297643Not applicable
- A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)Active, not recruitingNCT05296798Phase 3
- Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast CancerActive, not recruitingNCT05296746Phase 2
- Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide RegenerationCompletedNCT05296317Not applicable
- Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast CancerStatus unknownNCT05295043Not applicable
- Smart Bra for Diagnosing Breast CancerActive, not recruitingNCT05294016Not applicable
- Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT05293964Phase 1
- A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer PatientsCompletedNCT05291494Not applicable
- Use of Superparamagnetic Iron Oxide (SPIO) in Sentinel Lymph Node Detection for Breast CancerActive, not recruitingNCT05288686Not applicable
- QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.Status unknownNCT05287139
- Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic MeningitisCompletedNCT05286684Not applicable
- A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)CompletedNCT05283837Phase 3
- ZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONESCompletedNCT05280067Phase 2
- Noninvasive Assessment of Lymphedema Among Breast Cancer SurvivorsCompletedNCT05278871Not applicable
- Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.Active, not recruitingNCT05278741Not applicable
- An Individualised Treatment vs. a Minimal Program in Women With Late-term Shoulder Impairments After Breast Cancer.CompletedNCT05277909Not applicable
- First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsActive, not recruitingNCT05277051Phase 1
- Outcome of Tucidinostat-Based Therapy in HR+ Metastatic Breast Cancer Patients Previously Treated With CDK4/6 InhibitorStatus unknownNCT05276713
- Utilizing Social Contacts to Facilitate Mammogram Screening Among African American WomenCompletedNCT05275361Not applicable
- A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast CancerStatus unknownNCT05274893Phase 1
- Efficacy of Preoperative Radiotherapy for Non-responder Patients After Neoadjuvant ChemotherapyCompletedNCT05274594
- A Study to Investigate LYL797 in Adults With Solid TumorsTerminatedNCT05274451Phase 1
- Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese PatientsStatus unknownNCT05273944Phase 1
- Towards Early Detection of Breast Cancer in High Risk PopulationCompletedNCT05268913
- Atezolizumab Plus CArboplatin Plus Nab-paclitaxelActive, not recruitingNCT05266937Phase 2
- A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer PatientsActive, not recruitingNCT05266105Phase 1
- A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer SurvivorsCompletedNCT05265715Not applicable
- Gemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast CancerStatus unknownNCT05263882Phase 2
- A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer PatientsStatus unknownNCT05263869Phase 2
- An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)CompletedNCT05263362
- A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsActive, not recruitingNCT05262400Phase 1/2
- A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast CancerCompletedNCT05261269Phase 1
- RISE - Reduce Sitting Time Among Breast Cancer SurvivorsCompletedNCT05260723Not applicable
- Online Group Therapy for Breast CancerStatus unknownNCT05259267Not applicable
- Breast Cancer Prevention and Screening MembershipActive, not recruitingNCT05258539Not applicable
- An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant ChemotherapyStatus unknownNCT05258461Not applicable
- Reliability and Validity of The '6 Minute Pegboard and Ring Test' in Patients With Breast CancerCompletedNCT05258344
- Breathing Exercise for Chronic Pain Management in Breast Cancer SurvivorsCompletedNCT05257876Not applicable
- Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO)Active, not recruitingNCT05257577
- A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast CancerActive, not recruitingNCT05257395Phase 3
- Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)WithdrawnNCT05255666Phase 2
- Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast CancerStatus unknownNCT05255523Phase 2
- Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing ChemotherapyCompletedNCT05254678Not applicable
- Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast CancerStatus unknownNCT05253066Phase 2/3
- To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsCompletedNCT05253053Phase 1/2
- Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant NeratinibActive, not recruitingNCT05252988Phase 2
- A Community Dance Intervention Engaging Breast Cancer Survivors in a Middle-income CountryCompletedNCT05252780Not applicable
- NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsTerminatedNCT05252390Phase 1
- Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast CancerStatus unknownNCT05251766Phase 1
- CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast CancerActive, not recruitingNCT05251714Phase 1/2
- Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast CancerStatus unknownNCT05250336
- Frequency Domain Optical ImagingCompletedNCT05246735Not applicable
- Effect of the Axillary Lymphatic /Vein Reflux Ratio on Postoperative Upper Limb Edema and Dysfunction in Breast CancerCompletedNCT05246592
- Fertility Changes Due to Cancer: an Investigation of Meaning, Psychological Distress, and PsychologiWithdrawnNCT05245162
- AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast CancerStatus unknownNCT05244993Phase 2
- Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast CancerWithdrawnNCT05244434Not applicable
- The Effect of Self-compassion on Breast CancerStatus unknownNCT05240937Not applicable
- GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast CancerTerminatedNCT05239663Phase 3
- P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsActive, not recruitingNCT05239143Phase 1
- Study of INCB123667 in Subjects With Advanced Solid TumorsActive, not recruitingNCT05238922Phase 1
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
- Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node DissectionTerminatedNCT05236387
- The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream StudyCompletedNCT05234996Not applicable
- A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid TumorsWithdrawnNCT05234606Phase 1/2
- Effects of Ketogenic Diet in Overweight and Obese Women With Breast CancerStatus unknownNCT05234502Not applicable
- HER2-directed Biosimilar in Breast Cancer: Real World ePROCompletedNCT05234021
- Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBCWithdrawnNCT05233696Phase 2
- Different Volumes of Erector Spinae Plane Block for Breast SurgeryCompletedNCT05232084Not applicable
- Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world StudyStatus unknownNCT05231863
- Breast Cancer Self-Efficacy Scale for PartnersTerminatedNCT05228210
- Early Detection of Five Common Cancers Using the ctDNA Analysing TestCompletedNCT05227261
- Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast CancerWithdrawnNCT05227131Phase 2
- Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) StudiesActive, not recruitingNCT05226871Phase 2
- A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast CancerActive, not recruitingNCT05226663Phase 2
- Video Education With Result Dependent dIsclosureCompletedNCT05225428Not applicable
- Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT StudyCompletedNCT05224271
- Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial DysfunctionActive, not recruitingNCT05223322Not applicable
- Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility StudyCompletedNCT05222464Phase 4
- Effects of Moderate and High-intensity Exercise During Chemotherapy on Muscle Cells in Women With Breast CancerCompletedNCT05218876Not applicable
- Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 StatusCompletedNCT05217381
- Prehabilitation for Breast Cancer SurgeryCompletedNCT05216302Not applicable
- The Significance of Radiologically Detected Intramammary Lymph Nodes in Prediction of Axillary Lymph Nodes Status in Breast Cancer PatientsStatus unknownNCT05214781
- The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer PatientsCompletedNCT05214144
- Innovative "Scoring System" in Breast Cancer Post Neoadiuvant ChemotherapyCompletedNCT05213403
- To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast CancerWithdrawnNCT05212701Phase 2
- Chemo-free BRCA-targeted Neoadjuvant StrategyWithdrawnNCT05209529Phase 2
- Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic SubtypeTerminatedNCT05207709Phase 3
- Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast CancerTerminatedNCT05207514Phase 3
- Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast CancerCompletedNCT05206656Phase 2
- Dragonboat Activity for Breast CancerCompletedNCT05206526Not applicable
- CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective StudyCompletedNCT05206331Phase 4
- Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2CompletedNCT05203497Phase 1
- Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer PatientsCompletedNCT05203458
- Effectiveness of Aerobic Exercises and Laughter Yoga Compared With Yoga in Anxiety/Depression Levels in Breast CancerCompletedNCT05203029Not applicable
- Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast CancerStatus unknownNCT05200078
- Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment.Active, not recruitingNCT05196269Not applicable
- Inspiratory Muscle Training in Obese Breast Cancer SurvivorsCompletedNCT05193149Not applicable